Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Incretins/pharmacology"'
Autor:
Paul Johnson, Alejandra Tomas, Stephen R. Bloom, Piero Marchetti, Phoebe C Douzenis, Lorenzo Piemonti, Guy A. Rutter, Domenico Bosco, A. M. James Shapiro, Pauline Chabosseau, Ben Jones, Ivan R. Corrêa, Teresa Buenaventura, N Kanda
Publikováno v:
Diabetes, Vol. 67, No 3 (2018) pp. 385-399
The glucagon-like peptide 1 (GLP-1) receptor (GLP-1R) is a key target for type 2 diabetes (T2D) treatment. Because endocytic trafficking of agonist-bound receptors is one of the most important routes for regulation of receptor signaling, a better und
Autor:
Morten Frost, Moustapha Kassem, Jacob Stampe Frølich, Morten Steen Hansen, Michaela Tencerova
Publikováno v:
Hansen, M S S, Tencerova, M, Frølich, J, Kassem, M & Frost, M 2018, ' Effects of gastric inhibitory polypeptide, glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists on Bone Cell Metabolism ', Basic & Clinical Pharmacology & Toxicology, vol. 122, no. 1, pp. 25–37 . https://doi.org/10.1111/bcpt.12850
The relationship between gut and skeleton is increasingly recognised as part of the integrated physiology of the whole organism. The incretin hormones gastric inhibitory polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) are secreted from the inte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2be8e2e2be80de3e864c29ccfc45a303
https://findresearcher.sdu.dk:8443/ws/files/156523501/11.07.17_MSH.pdf
https://findresearcher.sdu.dk:8443/ws/files/156523501/11.07.17_MSH.pdf
Publikováno v:
Karstoft, K, Mortensen, S, Knudsen, S H & Solomon, T P J 2015, ' Direct effect of incretin hormones on glucose and glycerol metabolism and hemodynamics ', American Journal of Physiology: Endocrinology and Metabolism, vol. 308, no. 5, ajpendo.00520.2014, pp. E426-E433 . https://doi.org/10.1152/ajpendo.00520.2014
The objective of this study was to assess the insulin-independent effects of incretin hormones on glucose and glycerol metabolism and hemodynamics under euglycemic and hyperglycemic conditions. Young, healthy men ( n = 10) underwent three trials in a
Autor:
Ravassa, S. (Susana), Zudaire, A. (Amaia), Carr, R.D. (Richard D.), Diez-Martinez, J. (Javier)
Activation of apoptosis contributes to cardiomyocyte dysfunction and death in diabetic cardiomyopathy. The peptide glucagon-like peptide-1 (GLP-1), a hormone that is the basis of emerging therapy for type 2 diabetic patients, has cytoprotective actio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1111::93c2d2fb993c0046e2fe48f8e86957c1
https://hdl.handle.net/10171/21820
https://hdl.handle.net/10171/21820
Publikováno v:
Circulation: Heart Failure; Jan2016, Vol. 9 Issue 1, p1-10, 10p
Publikováno v:
Diabetologia; Sep2009 Supplement 1, Vol. 52, p1-550, 550p, 1 Color Photograph, 1 Illustration, 10 Diagrams, 146 Charts, 106 Graphs
Autor:
Holst, Jens J.
Publikováno v:
Diabetes, Obesity & Metabolism; Aug2008 Supplement 3, Vol. 10, p14-21, 8p, 1 Diagram, 2 Charts
Publikováno v:
AAPS Journal; Apr2008, Vol. 10 Issue 2, p401-409, 9p